Implications of placebo and nocebo effects for clinical practice: expert consensus AWM Evers, L Colloca, C Blease, M Annoni, LY Atlas, F Benedetti, ... Psychotherapy and psychosomatics 87 (4), 204-210, 2018 | 480 | 2018 |
Too many ‘friends,’too few ‘likes’? Evolutionary psychology and ‘Facebook depression’ CR Blease Review of General Psychology 19 (1), 1-13, 2015 | 265 | 2015 |
Epistemic injustice in healthcare encounters: evidence from chronic fatigue syndrome C Blease, H Carel, K Geraghty Journal of medical ethics 43 (8), 549-557, 2017 | 203 | 2017 |
Artificial intelligence and the future of primary care: exploratory qualitative study of UK general practitioners’ views C Blease, TJ Kaptchuk, MH Bernstein, KD Mandl, JD Halamka, ... Journal of medical Internet research 21 (3), e12802, 2019 | 198 | 2019 |
Artificial intelligence and the future of psychiatry: insights from a global physician survey PM Doraiswamy, C Blease, K Bodner Artificial intelligence in medicine 102, 101753, 2020 | 142 | 2020 |
Are open‐label placebos ethical? Informed consent and ethical equivocations C Blease, L Colloca, TJ Kaptchuk Bioethics 30 (6), 407-414, 2016 | 139 | 2016 |
Evidence-based practice and psychological treatments: the imperatives of informed consent CR Blease, SO Lilienfeld, JM Kelley Frontiers in psychology 7, 1170, 2016 | 105 | 2016 |
Informed consent and clinical trials: where is the placebo effect? CR Blease, FL Bishop, TJ Kaptchuk Bmj 356, 2017 | 75 | 2017 |
Go open: A plea for transparency in psychotherapy. J Gaab, C Blease, C Locher, H Gerger Psychology of Consciousness: Theory, Research, and Practice 3 (2), 175, 2016 | 74 | 2016 |
The principle of parity: the ‘placebo effect’and physician communication C Blease Journal of medical ethics 38 (4), 199-203, 2012 | 74 | 2012 |
Artificial intelligence and the future of psychiatry: qualitative findings from a global physician survey C Blease, C Locher, M Leon-Carlyle, M Doraiswamy Digital health 6, 2055207620968355, 2020 | 69 | 2020 |
Computerization and the future of primary care: a survey of general practitioners in the UK C Blease, MH Bernstein, J Gaab, TJ Kaptchuk, J Kossowsky, KD Mandl, ... PloS one 13 (12), e0207418, 2018 | 67 | 2018 |
Open-label placebo clinical trials: is it the rationale, the interaction or the pill? CR Blease, MH Bernstein, C Locher BMJ evidence-based medicine 25 (5), 159-165, 2020 | 64 | 2020 |
What should clinicians tell patients about placebo and nocebo effects? Practical considerations based on expert consensus AWM Evers, L Colloca, C Blease, J Gaab, KB Jensen, LY Atlas, ... Psychotherapy and Psychosomatics 90 (1), 49-56, 2020 | 60 | 2020 |
Myalgic encephalomyelitis/chronic fatigue syndrome and the biopsychosocial model: a review of patient harm and distress in the medical encounter KJ Geraghty, C Blease Disability and rehabilitation 41 (25), 3092-3102, 2019 | 60 | 2019 |
The ‘cognitive behavioural model’of chronic fatigue syndrome: Critique of a flawed model K Geraghty, L Jason, M Sunnquist, D Tuller, C Blease, C Adeniji Health Psychology Open 6 (1), 2055102919838907, 2019 | 57 | 2019 |
Sharing clinical notes and electronic health records with people affected by mental health conditions: scoping review J Schwarz, A Bärkås, C Blease, L Collins, M Hägglund, S Markham, ... JMIR mental health 8 (12), e34170, 2021 | 53 | 2021 |
Sharing notes with mental health patients: balancing risks with respect C Blease, S O'Neill, J Walker, M Haegglund, J Torous The Lancet Psychiatry, https://doi.org/10.1016/S2215-0366(20)30, 2020 | 48* | 2020 |
Patients, clinicians and open notes: information blocking as a case of epistemic injustice C Blease, L Salmi, H Rexhepi, M Hägglund, CM DesRoches Journal of Medical Ethics 48 (10), 785-793, 2022 | 47 | 2022 |
Cognitive behavioural therapy in the treatment of chronic fatigue syndrome: A narrative review on efficacy and informed consent KJ Geraghty, C Blease Journal of health psychology 23 (1), 127-138, 2018 | 45 | 2018 |